The angiotensin II receptor blocker (ARB) candesartan cilexetil decreases portal vascular resistance in liver cirrhosis

被引:0
|
作者
Ito, M
Hachiya, A
Nakano, S
Hanzawa, M
Katagiri, M
Kurita, T
Matsuzaki, H
Igarashi, Y
Iida, K
Miki, K
机构
关键词
D O I
10.1016/S0016-5085(03)83358-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A663 / A663
页数:1
相关论文
共 50 条
  • [1] Candesartan cilexetil: An angiotensin II receptor blocker
    Stoukides, CA
    McVoy, HJ
    Kaul, AF
    [J]. ANNALS OF PHARMACOTHERAPY, 1999, 33 (12) : 1287 - 1298
  • [2] Angiotensin II receptor blocker: Candesartan cilexetil
    Inada, Y
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 35P - 35P
  • [3] Candesartan cilexetil: An angiotensin II-receptor blocker
    See, S
    Stirling, AL
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (08) : 739 - 746
  • [4] Effect of the angiotensin II receptor antagonist (AT-IIRA) candesartan cilexetil on portal blood flow in liver cirrhosis
    Ito, M
    Hachiya, A
    Fujii, M
    Katagiri, M
    Nakano, S
    Kurita, T
    Matsuzaki, H
    Iida, K
    Miki, K
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A656 - A656
  • [5] Angiotensin II receptor antagonists: Candesartan cilexetil
    Naka, T
    Kubo, K
    Nishikawa, K
    Inada, Y
    Furukawa, Y
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2000, 120 (12): : 1261 - 1275
  • [6] Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy
    Shirai, K
    Watanabe, K
    Ma, ML
    Wahed, MII
    Inoue, M
    Saito, Y
    Suresh, PS
    Kashimura, T
    Tachikawa, H
    Kodama, M
    Aizawa, Y
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2005, 269 (1-2) : 137 - 142
  • [7] Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy
    Ken Shirai
    Kenichi Watanabe
    Meilei Ma
    Mir I I Wahed
    Mikio Inoue
    Yuki Saito
    Palaniyandi Selvaraj Suresh
    Takeshi Kashimura
    Hitoshi Tachikawa
    Makoto Kodama
    Yoshifusa Aizawa
    [J]. Molecular and Cellular Biochemistry, 2005, 269 : 137 - 142
  • [9] Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil
    Sever, PS
    [J]. JOURNAL OF HYPERTENSION, 1997, 15 : S9 - S12
  • [10] The angiotensin II receptor antagonist candesartan is not effective in reducing portal hypertension in patients with cirrhosis
    Heim, Markus H.
    Jacob, Ludwig
    Beglinger, Christoph
    [J]. DIGESTION, 2007, 75 (2-3) : 122 - 123